Related Experiment Video
Updated: May 15, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
Penile cancer: current therapy and future directions
G Sonpavde1, L C Pagliaro, C Buonerba
1Department of Medicine, Section of Medical Oncology, UAB Comprehensive Cancer Center, Birmingham.
Penile cancer (PC) is rare but aggressive, often spreading to lymph nodes (LNs). Evaluating LNs is crucial for survival, with advanced cases benefiting from multimodal therapy, but treatment advances require international collaboration and research.
Area of Science:
- Oncology
- Urology
- Cancer Research
Background:
- Penile cancer (PC) is a rare malignancy in Western countries, more prevalent in developing regions.
- Limited randomized trials necessitate reliance on retrospective and small prospective studies for treatment strategies.
- PC is characterized by aggressive behavior, including early locoregional lymph node (LN) spread and distant metastases.
Purpose of the Study:
- To review current therapeutic approaches for penile cancer.
- To identify critical factors influencing patient survival, particularly lymph node involvement.
- To explore potential avenues for future advancements in PC treatment.
Main Methods:
- A literature search was conducted using PubMed.
- Abstracts from major oncology conferences were reviewed.
- Studies focusing on penile cancer therapy were included.
Main Results:
- Lymph node involvement is a critical predictor of overall survival in PC.
- Advanced LN involvement is managed with multimodality therapy (chemotherapy and/or radiation).
- No single superior cisplatin-based regimen has been established.
Conclusions:
- Future progress in PC therapy hinges on international collaboration, understanding tumor biology, and efficient trial designs.
- Potential therapeutic advances may arise from investigating the role of circumcision, Human Papilloma Virus-16, and smoking.
- Emerging strategies include targeting epidermal growth factor receptor and angiogenesis.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Tumor Immunotherapy
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

